Through purpose-driven science, empowering medicines, and transformative advocacy we seek to improve the lives of millions.
Our areas of focus
An estimated 19 million women in the U.S. have uterine fibroids.
An estimated 7.5 million premenopausal women in the U.S. have endometriosis.
Approximately 3 million men alive today in the U.S. have been diagnosed with prostate cancer.
Myovant is developing innovative medicines that hold promise to improve people’s lives.
16 Sep 2022
Myovant Recognizes Prostate Cancer Awareness Month with Educational Sponsorships and Online Campaign to Encourage Patients to Speak Up, Seek Support and Be Informed
30 Jun 2022
Myovant Statement: U.S. Supreme Court Ruling in Dobbs v. Jackson Women’s Health Organization
You are leaving www.myovant.com, a website provided by Myovant Sciences GmbH.
This link will take you to a different site.